Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Kissei Pharmaceutical Co ( (JP:4547) ) has shared an update.
Kissei Pharmaceutical Co., Ltd. has completed the acquisition of 1,369,200 treasury shares, representing 3.20% of its issued shares, for a total cost of 5,216,652,000 yen. This move is part of a flexible capital policy aimed at improving capital efficiency and enhancing shareholder returns, with the acquired shares set to be canceled by June 27, 2025.
More about Kissei Pharmaceutical Co
Kissei Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of medical products. The company is listed on the Tokyo Stock Exchange and aims to enhance shareholder value through strategic financial maneuvers.
Average Trading Volume: 72,057
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen160.2B
See more insights into 4547 stock on TipRanks’ Stock Analysis page.